Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

Clinical trial NCT00310817 · COMPLETED

Trial details

NCT number: NCT00310817
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Meningitis

Start date: 2005-03-01
Primary completion: 2006-05-01
Enrollment: 623

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.